The development of insulin resistance in a murine model of intermittent hypoxia Source: Research Seminar 2007 - Metabolic Aspects of the Obstructive Sleep Apnea Syndrome (OSAS) Year: 2007
Hyperinsulinemia due to altered insulin secretion contributes to insulin resistance in chronic intermittent hypoxia independently of obesity Source: International Congress 2019 – Insights into the pathophysiology of sleep-disordered breathing Year: 2019
Leptin, visfatin, insulin resistance, body composition change in chronic obstructive pulmonary disease Source: Annual Congress 2010 - COPD: phenotyping and monitoring Year: 2010
Insulin resistance in pulmonary arterial hypertension Source: Eur Respir J 2009; 33: 318-324 Year: 2009
Type 2 diabetes-related “pulmonary insulin resistance” as a novel mechanism that complicates COPD phenotypes in mice Source: International Congress 2017 – Novel molecular and genetic targets in COPD Year: 2017
Impact of therapies on insulin resistance in pulmonary arterial hypertension Source: Annual Congress 2010 - Pulmonary circulation: clinical aspects Year: 2010
Peripheral insulin resistance accounts for impaired glucose tolerance and is associated with systemic inflammation in COPD Source: Annual Congress 2011 - New mechanisms in airway disease Year: 2011
No indication of insulin resistance in idiopathic pulmonary arterial hypertension with preserved physical activity Source: Eur Respir J, 55 (6) 1901228; 10.1183/13993003.01228-2019 Year: 2020
Evaluation of association between COPD and metabolic syndrome, and insulin resistance Source: Annual Congress 2012 - COPD comorbidities II Year: 2012
Role of anti-proliferative therapy in PAH Source: Research Seminar 2008 - The Pulmonary Circulation: Scleroderma-Related Pulmonary Arterial Hypertension Year: 2008
Serotonin transporter genes, pulmonary haemodynamics and pulmonary hypertension Source: Annual Congress 2005 - Scientific year in review Year: 2005
Bosentan improves exercise tolerance and Tei index in patients with pulmonary hypertension and prostanoid therapy Source: Annual Congress 2005 - Treatment of pulmonary arterial hypertension Year: 2005
R667 retinoid agonist modulates blood glucose in COPDe patients with improved metabolic profile compared to ATRA Source: Annual Congress 2007 - New drugs for COPD Year: 2007
Time course of insulin antibody response during inhaled insulin therapy does not correlate with changes in pulmonary function Source: Eur Respir J 2005; 26: Suppl. 49, 375s Year: 2005
The arterial load in pulmonary hypertension Source: Eur Respir Rev 2010 19: 197-203 Year: 2010
Leptin and regulatory T-lymphocytes in idiopathic pulmonary arterial hypertension}, Source: Eur Respir J 2012; 40: 895-904 Year: 2012
Metabolic syndrome and diabetes mellitus in COPD Source: Eur Respir Mon 2013; 59: 117-134 Year: 2013
Leptin in relation to systemic inflammation and regulation of the energy balance Source: ISSN=1025-448x, ISBN=1-904097-27-8, page=56 Year: 2003
The effects and mechanisms of chronic intermittent hypoxia on insulin resistance and glucose tolerance in non-obese rats Source: Annual Congress 2013 –Of mice and men: sleep disordered breathing Year: 2013
No indication of insulin resistance in idiopathic PAH with preserved physical activity Source: Virtual Congress 2020 – Experimental approaches to pulmonary hypertension Year: 2020